compounding glp-1 news FDA Intensifies Crackdown on BREAKING NEWS in the compounding

We provide a flexible and personalized dosage plan for injectable GLP to meet your unique health needs

A recently published, randomized, placebo-controlled trial found a greater reduction in BMI z-score (0.22 SDs) in adolescents receiving liraglutide compared with placebo

2024 Jan;38(1):117-130

India Issues Urgent GLP-1 Drug Safety Alert The Indian Pharmacopoeia Commission (IPC) has issued a public notice on 14 May calling on doctors, patients, and consumers to closely monitor and report any adverse reactions linked to semaglutide and other GLP-1 receptor agonists including dulaglutide, liraglutide, and tirzepatide

### Competing Interest Statement ASK, AMM, MCG, JMD, CB, CL, SWB, DJL, PML, DRD, JMC, JPF, YL, ARS, DAT, DWP, SH, RBR, MSL, and DAG are employees and stockholders of Pfizer Inc

From NYC to Buffalo, our statewide telehealth service allows you to meet with a licensed provider quickly and safely often with same-day appointments